ABBV
AbbVie, Inc. · BMV:ABBV
5,545.00 MXN85.00 +1.56%
AbbVie, Inc. (BMV:ABBV) last traded at 5,545.00 MXN, up 1.56% on the day. Over the past year the stock is up 32.02%. Its 52-week range is 3,420.00 to 5,582.00. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open5,582.00
Day range5,544.00 – 5,582.00
52-week range3,420.00 – 5,582.00
Volume58
Average volume (10 days)196
Market cap (USD)521.11 B
P/E52.70
EPS (TTM) (USD)5.82
Dividend yield2.32%
Beta (1 year)−0.2780
Revenue (TTM) (USD)66.01 B
Employees57.00 K
Performance
+4.48%1 week
+16.13%1 month
+26.45%3 months
+48.62%6 months
+34.14%Year to date
+32.02%1 year
Technical rating
Strong buy
Daily summary of 11 oscillators and 15 moving averages. See every indicator
Analysts’ target
5,687.16 MXN
The average 1-year price target, +2.56% from the last price. See the forecast
Latest headlines
- The top 5 analyst questions from AbbVie’s Q3 earnings callStock Story · 01 Nov 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Key facts: AbbVie, Inc. Q3 revenue $17.404B; Skyrizi approved; lutikizumab successTradingView · 31 Oct 2026
- ABBV Q3 deep dive: Immunology and neuroscience drive growth, pipeline progress continuesStock Story · 31 Oct 2026
- AbbVie Inc. Stock 12‑Month Price Target Raised to $291TradingView · 30 Oct 2026
- LLY, ABBV Stocks Hit All-Time High – Here’s What’s Driving Investor Enthusiasm TodayStocktwits · 30 Oct 2026
- AbbVie Stocks Rise 1.75% With Two Medicines Providing Nearly Half of RevenueGuruFocus · 30 Oct 2026
- What AbbVie (ABBV) Said on Its Q3 Earnings CallMarketBeat · 30 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.